Correction: Sonoporation by microbubbles as gene therapy approach against liver cancer

Luca Rinaldi; Veronica Folliero; Luciana Palomba; Carla Zannella; Rachele Isticato; Raffaele Di Francia; Massimiliano Berretta; Ilario de Sio; Luigi E. Adinolfi; Giancarlo Morelli; Secondo Lastoria; Lucia Altucci; Carlo Pedone; Massimiliano Galdiero; Gianluigi Franci

doi:10.18632/oncotarget.26305

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Sonoporation by microbubbles as gene therapy approach against liver cancer

PDF | How to cite

Oncotarget. 2018; 9:35600-35600. https://doi.org/10.18632/oncotarget.26305

Metrics: PDF 1556 views | ?

Luca Rinaldi¹, Veronica Folliero², Luciana Palomba², Carla Zannella², Rachele Isticato³, Raffaele Di Francia⁴, Massimiliano Berretta⁵, Ilario de Sio⁶, Luigi E. Adinolfi¹, Giancarlo Morelli⁷, Secondo Lastoria⁸, Lucia Altucci⁶, Carlo Pedone⁷, Massimiliano Galdiero² and Gianluigi Franci²

¹ Department of Medical, Surgical, Neurological, Metabolic and Aging Science, University of Campania “Luigi Vanvitelli”, Naples, Italy
² Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy
³ Department of Biology, Federico II University, Naples, Italy
⁴ Department of Hematology, National Cancer Institute, Foundation G. Pascale IRCCS, Naples, Italy
⁵ Department of Medical Oncology, National Cancer Institute IRCCS, Aviano, Italy
⁶ Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy
⁷ Department of Pharmacology, Federico II University, Naples, Italy
⁸ Department of Diagnostic Imaging, Radiation and Metabolic Therapy, National Cancer Institute, Foundation G. Pascale IRCCS, Naples, Italy

Published: October 30, 2018

This article has been corrected: The correct Acknowledgement information is given below:

ACKNOWLEDGMENTS

Blueprint 282510; MIUR20152TE5PK; COST-H2020: EPICHEMBIO CM1406; AIRC-17217; RISE-H2020: Ocean Medicine, PROGRAMMA VALERE provided the publication fee for the manuscript.

Original article: Oncotarget. 2018; 9:32182-32190. DOI: https://doi.org/10.18632/oncotarget.25875.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26305

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: Sonoporation by microbubbles as gene therapy approach against liver cancer